Drug details

Spritam (levetiracetam tablets)

type of Ligands

Spritam (levetiracetam) is an epilepsy medicine indicated for adjunctive therapy in the treatment of partial onset seizures in patients with epilepsy 4 years of age and older weighing more than 20 kg; myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy; and primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.

The drug is often used to treat Epilepsy .

This drug may have the following side effects:

• tiredness,
• aggression,
• decreased appetite,
• irritability, and
• nasal congestion

The following drugs are related to Spritam, either as a replacement or used together:

• Diamox Sequels (acetazolamide xr)
• Tegretol (carbamazepine)
• Epitol (carbamazepine tablets)
• Carnitor (levocarnitine tablets, oral solution, sugar-free)
• Carnitor Injection (levocarnitine injection)
• Klonopin (clonazepam)
• Zarontin (ethosuximide)
• Zarontin Oral Solution (ethosuximide oral solution)
• Peganone (ethotoin)
• Neurontin (gabapentin)
• Gabitril (tiagabine hydrochloride)
• Keppra (levetiracetam)
• Keppra Injection (levetiracetam)
• Keppra XR (levetiracetam extended-release tablets)
• Vimpat (lacosamide tablet and injection)
• Topamax (topiramate)
• Trokendi XR (topiramate extended-release capsules)